β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic β INS832/13 cells

Molecular and Cellular Endocrinology

Volumn 364, Issue 1-2, 2012, Pages 65-70

  Talbot, Jason ^a   Joly, Erik ^b   Prentki, Marc ^b   Buteau, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Arrestin; Cell mass; C Src; GLP 1; Incretin; Proliferation

Indexed keywords

BETA ARRESTIN 1; G PROTEIN COUPLED RECEPTOR; PROTEIN KINASE P60;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADULT; AGED; ARRESTINS; CELL PROLIFERATION; CLATHRIN; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; IMMUNOPRECIPITATION; INSULIN-SECRETING CELLS; MIDDLE AGED; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; RECEPTORS, GLUCAGON; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84867514722     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.08.010     Document Type: Article

References (30)

1. Bonner-Weir S. Perspective: postnatal pancreatic β-cell growth. Endocrinology 2000, 141:1926-1929.
2. Bonner-Weir S., Sharma A. Pancreatic stem cells. J. Pathol. 2002, 197:519-526.
3. Brubaker P.L., Drucker D.J. Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 2002, 8:179-188.
4. Buteau J., El-Assaad W., Rhodes C.J., Rosenberg L., Joly E., Prentki M. Glucagon-like peptide-1 prevents β-cell glucolipotoxicity. Diabetologia 2004, 47:806-815.
5. Buteau J., Foisy S., Joly E., Prentki M. Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003, 52:124-132.
6. Buteau J., Foisy S., Rhodes C.J., Carpenter L., Biden T.J., Prentki M. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation. Diabetes 2001, 50:2237-2243.
7. Buteau J., Roduit R., Susini S., Prentki M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in β (INS-1)-cells. Diabetologia 1999, 42:856-864.
8. Buteau J., Spatz M.L., Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass. Diabetes 2006, 55:1190-1196.
9. Cornu M., Yang J.Y., Jaccard E., Poussin C., Widmann C., Thorens B. Glucagon-like peptide-1 protects β-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes 2009, 58:1816-1825.
10. Drucker D.J. The biology of incretin hormones. Cell Metab. 2006, 3:153-165.
11. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
12. Edlund H. Pancreatic organogenesis-developmental mechanisms and implications for therapy. Nat. Rev. Genet. 2002, 3:524-532.
13. Farilla L., Hui H., Bertolotto C., Kang E., Bulotta A., Di Mario U., Perfetti R. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 2002, 143:4397-4408.
14. Fehmann H.C., Habener J.F. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma β TC-1 cells. Endocrinology 1992, 130:159-166.
15. Gromada J., Bokvist K., Ding W.G., Holst J.J., Nielsen J.H., Rorsman P. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 1998, 47:57-65.
16. Gutniak M., Orskov C., Holst J.J., Ahren B., Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with Diabetes mellitus. N. Engl. J. Med. 1992, 326:1316-1322.
17. Hohmeier H.E., Mulder H., Chen G., Henkel-Rieger R., Prentki M., Newgard C.B. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000, 49:424-430.
18. Holz G.G., Kuhtreiber W.M., Habener J.F. Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993, 361:362-365.
19. Holz G.G.t., Leech C.A., Habener J.F. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J. Biol. Chem. 1995, 270:17749-17757.
20. Kang G., Chepurny O.G., Holz G.G. CAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic β-cells. J. Physiol. 2001, 536:375-385.
21. Li Y., Hansotia T., Yusta B., Ris F., Halban P.A., Drucker D.J. Glucagon-like peptide-1 receptor signaling modulates β-cell apoptosis. J. Biol. Chem. 2003, 278:471-478.
22. Liu, Z., Habener, J.F., 2008. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic β-cell proliferation, J Biol Chem.
23. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., Lin F., Kawakatsu H., Owada K., Luttrell D.K., Caron M.G., Lefkowitz R.J. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 1999, 283:655-661.
24. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 Diabetes mellitus. J. Clin. Invest. 1993, 91:301-307.
25. Pierce K.L., Lefkowitz R.J. Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors. Nat. Rev. Neurosci. 2001, 2:727-733.
26. Quoyer J., Longuet C., Broca C., Linck N., Costes S., Varin E., Bockaert J., Bertrand G., Dalle S. GLP-1 mediates antiapoptotic effect by phosphorylating bad through a β-arrestin 1-mediated ERK1/2 activation in pancreatic β-cells. J. Biol. Chem. 2010, 285:1989-2002.
27. Sonoda N., Imamura T., Yoshizaki T., Babendure J.L., Lu J.C., Olefsky J.M. β-Arrestin1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β-cells. Proc. Nat. Acad. Sci. USA. 2008, 105:6614-6619.
28. Stoffers D.A., Kieffer T.J., Hussain M.A., Drucker D.J., Bonner-Weir S., Habener J.F., Egan J.M. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000, 49:741-748.
29. Syme C.A., Zhang L., Bisello A. Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol. Endocrinol. 2006, 20:3400-3411.
30. Zhang X., Wang F., Chen X., Li J., Xiang B., Zhang Y.Q., Li B.M., Ma L. β-Arrestin1 and β-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors. J. Neurochem. 2005, 95:169-178.